Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (161-170 of 349) with videos related to

Pageof 35
Sort By:
Journal of the Endocrine Society|March 11, 2025
Cardiovascular Risk and Plasma N-terminal Pro-B-type Natriuretic Peptide in Adults With Resistance to Thyroid Hormone βTimothy M E Davis, Wendy A Davis, Carla Moran, et al.
Plos Neglected Tropical Diseases|May 4, 2010
Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replicationClaudia Bönsch, Christoph Kempf, Ivo Mueller, et al.
Cardiovascular Diabetology|June 27, 2022
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Timothy M E Davis, Anna Giczewska, Yuliya Lokhnygina, et al.
Internal Medicine Journal|July 18, 2019
Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase IITatsiana Yarash, Imrana Sharif, Farhat Masood, et al.
European Journal of Endocrinology|August 16, 2012
Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes StudyDianna J Magliano, Wendy A Davis, Jonathan E Shaw, et al.
Annals of Neurology|October 27, 2010
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trialOsvaldo P Almeida, Kylie Marsh, Helman Alfonso, et al.
Diabetologia|October 9, 2016
Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase IWendy A Davis, Renate R Zilkens, Sergio E Starkstein, et al.
Internal Medicine Journal|December 13, 2017
Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes StudyTimothy M E Davis, Stephen A P Chubb, Bradley H Curtis, et al.
Diabetes Technology & Therapeutics|July 3, 2014
Carotid artery ultrasonographic assessment in patients from the Fremantle Diabetes Study Phase II with carotid bruits detected by electronic auscultationArthur Knapp, Violetta Cetrullo, Brett A Sillars, et al.
Diabetes Care|December 8, 2018
Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase IIJocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, et al.
Pageof 35

Showing results (161-170 of 349) with videos related to

Sort By:
Pageof 35
Journal of the Endocrine Society|March 11, 2025
Cardiovascular Risk and Plasma N-terminal Pro-B-type Natriuretic Peptide in Adults With Resistance to Thyroid Hormone βTimothy M E Davis, Wendy A Davis, Carla Moran, et al.
Plos Neglected Tropical Diseases|May 4, 2010
Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replicationClaudia Bönsch, Christoph Kempf, Ivo Mueller, et al.
Cardiovascular Diabetology|June 27, 2022
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Timothy M E Davis, Anna Giczewska, Yuliya Lokhnygina, et al.
Internal Medicine Journal|July 18, 2019
Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase IITatsiana Yarash, Imrana Sharif, Farhat Masood, et al.
European Journal of Endocrinology|August 16, 2012
Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes StudyDianna J Magliano, Wendy A Davis, Jonathan E Shaw, et al.
Annals of Neurology|October 27, 2010
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trialOsvaldo P Almeida, Kylie Marsh, Helman Alfonso, et al.
Diabetologia|October 9, 2016
Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase IWendy A Davis, Renate R Zilkens, Sergio E Starkstein, et al.
Internal Medicine Journal|December 13, 2017
Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes StudyTimothy M E Davis, Stephen A P Chubb, Bradley H Curtis, et al.
Diabetes Technology & Therapeutics|July 3, 2014
Carotid artery ultrasonographic assessment in patients from the Fremantle Diabetes Study Phase II with carotid bruits detected by electronic auscultationArthur Knapp, Violetta Cetrullo, Brett A Sillars, et al.
Diabetes Care|December 8, 2018
Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase IIJocelyn J Drinkwater, Timothy M E Davis, Angus W Turner, et al.
Pageof 35